Afuco™ Anti-IGF1R ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-209) (CAT#: AFC-TAB-209)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IGF1 Receptor. It is a monoclonal antibody and an antineoplastic by Schering-Plough. It binds to CD221, the insulin-like growth factor 1 receptor.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Formats:

  • Isotype Switching:

  • Fc Engineering:

  • Modalities:

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:
Isotype :
Purity :
Endotoxin :
Quantity :
Conjugation :
Fc Engineering :
Modalities :
Other Requirements:
We require custom production
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP
  • Conjugate
  • Unconjugated
  • Generic Name
  • Robatumumab
  • Related Disease
  • Blood cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • IGF1R; insulin-like growth factor 1 receptor; CD221; IGFIR; IGFR; JTK13; MGC18216; IGF-I receptor; soluble IGF1R variant 1; soluble IGF1R variant 2; insulin-like growth factor I receptor;

Related Resources

  • Biosimilar Overview
  • Related Signaling Pathways
  • Related Diseases
Please refer to Robatumumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Robatumumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Robatumumab"

DrugMonitor™ Anti-Robatumumab Antibody (VS-1224-YC1028)
Robatumumab is a monoclonal antibody with antineoplastic properties, studied in trials for conditions like osteosarcoma, Ewing's sarcoma, and peripheral neuroectodermal tumor. The DrugMonitor™ Anti-Robatumumab Antibody (VS-1224-YC1028) is an anti-drug antibody (ADA) against Robatumumab. This drug-based antibody is raised in mice immunized with the Robatumumab. The anti-Robatumumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Robatumumab in samples.

See other products for "IGF1R"

Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibodies Immunotoxins ADCC Enhanced Antibodies Humanized Antibodies Human Antibodies Chimeric Antibodies Mouse Antibodies Chicken IgY Antibodies Neutralizing Antibodies Blocking Antibodies Rabbit Monoclonal Antibodies Fab Antibodies IgG Antibodies Neuroscience Antibodies ScFv Antibodies Antibody Magnetic Beads ScFv-Fc Chimeras IHC Kits & Antibodies Extracellular Vesicle Antibodies Biparatopic Antibodies

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-209. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare